Noah Goodman, MBA

Noah Goodman, MBA

Chief Business OfficeratKymera Therapeutics· In the 2025 proxy

Pay in FY2025Kymera Therapeutics stock +93.4% the same year

Noah Goodman, MBA was paid $3.2M in FY2025 (Dec). Kymera Therapeutics stock rose 93.4% that year.

Pay$100 in the stock at the end of FY24 → $193
Pay is from the Summary Compensation Table of each Kymera Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Kymera TherapeuticsPublic company · 1 yr
    • Chief Business Officer2025 – Present · 1 yrStock in role +200%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?